Found 410 articles for: "General Medical Dermatology"
-
Error: 429: HTTP/2 429
Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib
April 2026 | Volume 25 | Issue 4 | | 384 | Copyright © April 2026
Introduction: JAK inhibitors are increasingly being utilized for the treatment of diseases beyond their nonclassical indications, and thehighly selective JAK1 inhibi...
Read MoreError: 429: HTTP/2 429Exosome-Based Therapies in Dermatology: A Scoping Review
April 2026 | Volume 25 | Issue 4 | | 368 | Copyright © April 2026
Background: In pre-clinical studies, exosomes activate dermal repair mechanisms, and they may show regenerative potential for skin rejuvenation, pigmentation, scarring, hair loss...
Read MoreError: 429: HTTP/2 429Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations
April 2026 | Volume 25 | Issue 4 | | 363 | Copyright © April 2026
Hydroquinone has long served as the gold standard for hyperpigmentation treatment, but safety concerns, regulatory changes, and growing interest in non-hydroquinone therapies have prompted reeval...
Read MoreError: 429: HTTP/2 429Patient Interest in Dermatologists in the United States: A 20-Year Google Trends and Workforce Analysis
April 2026 | Volume 25 | Issue 4 | | 357 | Copyright © April 2026
Background: Dermatologists remain unevenly distributed throughout the United States (US), leading to disparities in access to dermatologic care.Objective:Read MoreError: 429: HTTP/2 429The State of Primary Hyperhidrosis: Therapeutic Advancements and National Representation
April 2026 | Volume 25 | Issue 4 | | 397 | Copyright © April 2026
The Dermoepidermal Junction as the Initiation Point for Reversal of Dermatoporosis
April 2026 | Volume 25 | Issue 4 | | 377 | Copyright © April 2026
Background: Dermatoporosis (DP) or chronic cutaneous fragility syndrome has traditionally been linked to extracellular matrix (ECM) dehydration, reduced cellular turnover, epider...
Read MoreError: 429: HTTP/2 429Objective Measures Needed: Dermatology Program Directors' Perspectives on the USMLE Step 1 Pass/Fail Transition
April 2026 | Volume 25 | Issue 4 | | 345 | Copyright © April 2026
Background: Since January 2022, the United States Medical Licensing Examination (USMLE) Step 1 discontinued reporting a 3-digit score. The objective of this study is to share sur...
Read MoreError: 429: HTTP/2 429Remibrutinib: Insights Into Its Mechanism of Action and Use for Dermatologic Conditions
April 2026 | Volume 25 | Issue 4 | | 311 | Copyright © April 2026
Objective: Chronic spontaneous urticaria (CSU) is a chronic, debilitating condition characterized by recurrent wheals and/or angioedema. Several cytokines have been linked to CSU...
Read MoreError: 429: HTTP/2 429Beyond Efficacy: 0.6% Selenium Disulfide Shampoo Matches 2% Ketoconazole for Seborrheic Dermatitis with Superior Cosmesis
April 2026 | Volume 25 | Issue 4 | | 338 | Copyright © April 2026
Background: Although most dandruff shampoos are effective, many leave hair dry and unmanageable, potentially impacting patient compliance and treatment outcomes.Obje...
Read MoreError: 429: HTTP/2 429Association Between Topical Ruxolitinib Treatment and Psychiatric Outcomes in Adults With Vitiligo
April 2026 | Volume 25 | Issue 4 | | 388 | Copyright © April 2026
Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training
April 2026 | Volume 25 | Issue 4 | | e41 | Copyright © April 2026
Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer's Disease and Dementia
March 2026 | Volume 25 | Issue 3 | | 234 | Copyright © March 2026
Background: Alzheimer's disease (AD) and dementia create major global health and economic burdens. Herpes simplex virus (HSV) infects over 3 billion people, and chronic infection...
Read MoreError: 429: HTTP/2 429Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
March 2026 | Volume 25 | Issue 3 | | 204 | Copyright © March 2026
Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss on the scalp and body, leading to a reduced quality of life and psychosocial burden for patients. The only US ...
Read MoreError: 429: HTTP/2 429Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema
March 2026 | Volume 25 | Issue 3 | | 228 | Copyright © March 2026
Background: Chronic hand eczema (CHE) is a common, heterogeneous inflammatory skin disease associated with substantial symptom burden, impaired hand function, reduced quality of ...
Read MoreError: 429: HTTP/2 429Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series
March 2026 | Volume 25 | Issue 3 | | 951 | Copyright © March 2026
Background: Androgenetic alopecia (AGA) is the most common cause of hair loss. To minimize systemic adverse effects of 5-alpha-reductase inhibitors, dutasteride mesotherapy has g...
Read MoreError: 429: HTTP/2 429Pseudo-Psoriatic Nail Dystrophy Associated With Cosmetic Nail Products
March 2026 | Volume 25 | Issue 3 | | 256 | Copyright © March 2026
Pseudo-psoriatic nail dystrophy, a form of allergic contact dermatitis (ACD) secondary to nail product use, often mimics nail changes associated with psoriasis, leading to diagnostic delays. This...
Read MoreAdvanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel
March 2026 | Volume 25 | Issue 3 | Original Article | 221 | Copyright © March 2026
Background: Advanced topical nonsteroidal therapies are expanding options for atopic dermatitis (AD) by providing targeted anti-inflammatory control without many limitations of l...
Read MoreError: 429: HTTP/2 429Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
March 2026 | Volume 25 | Issue 3 | | 240 | Copyright © March 2026
Androgenetic alopecia (AGA) is a common, progressive form of nonscarring hair loss, affecting both men and women. Its pathogenesis is largely driven by androgenic factors, including elevated dihy...
Read MoreError: 429: HTTP/2 429Baricitinib-Related Adverse Events in Alopecia Areata and Rheumatoid Arthritis: A Comparative Study
March 2026 | Volume 25 | Issue 3 | | 286 | Copyright © March 2026
Patient Perspectives and Attitudes Toward the Diagnostic Process for Central Centrifugal Cicatricial Alopecia
March 2026 | Volume 25 | Issue 3 | Features | 282 | Copyright © March 2026
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
